Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial.

Similarly, according to locally assessed mRECIST criteria, more patients in group 2 achieved an objective response or disease control although these did not reach statistical significance.

also in 111,027 other papers